Common side effects involve mild to moderate GI symptoms
This blog post will focus strictly on pantothenic acid as an oral supplement as thats what has been used in acne studies
Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
Tirzepatide has a greater affinity for the GIP receptor, which is believed to be more powerful
Tirzepatide targets two incretin pathways simultaneously for enhanced appetite regulation and metabolic improvement
Adipose tissue is a site of energy storage and an active organ with important endocrine functions